Company / R&D per Share
Twist Bioscience Corp R&D per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.34
FY2025
5-year range
$1.34 / $2.23
FY2021-FY2025
Trend
-14.3%
vs FY2024
Sector context
#133 of 207
Health Care
What the data says
At $1.34, Twist Bioscience Corp's r&d per share ranks #133 of 207 in the Health Care sector. R&D per Share has declined for 3 consecutive years, from $2.23 in FY2022 to $1.34 in FY2025.
Based on SEC 10-K filings.
1.34 in FY2025 with a 5-year CAGR of +4.1%.
Declined from $1.88 to $1.34 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -15.6%
- 5-Year CAGR
- +4.1%
- 10-Year CAGR
- -
Sector benchmark
#133 of 207 in Health CareTop 64% of 207This company $1.34 Sector average $12.26
▼
-89.0% below sector average
Key checks
Key Insights
- Twist Bioscience Corp's r&d per share has declined for 3 consecutive years.
- In FY2025, r&d per share decreased 14.3% year-over-year.
- Ranks #133 out of 207 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.34 | -14.3% |
| FY2024 | $1.57 | -16.7% |
| FY2023 | $1.88 | -15.8% |
| FY2022 | $2.23 | +56.0% |
| FY2021 | $1.43 | +30.4% |
| FY2020 | $1.10 | -15.5% |
| FY2019 | $1.30 | -100.0% |
| FY2018 | $7285.00 | +92054967.7% |
| FY2017 | $0.01 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026